BUY SIBU-MED (SIBUTRAMINE) (20 MG/TAB. – 60 TABS) ONLINE

Key product details:

• Active Ingredient: Sibutramine hydrochloride monohydrate
• Strength: 20 mg per tablet
• Dosage Form: Tablet
• Route: Oral
• Pack Size: 60 tablets
• Indication: Management of obesity, according to the supplied information
• Dosage: As directed and supervised by a physician
• Market Status: Prescription

---

Main Product Description

Sibu-Med (Sibutramine) 20 mg is an orally administered medicinal product containing sibutramine hydrochloride monohydrate. Each tablet contains 20 mg of sibutramine hydrochloride, and the product is supplied in a pack of 60 tablets.

According to the supplied product information, sibutramine hydrochloride monohydrate is an agent used for the management of obesity. Its stated use includes supporting weight loss and the maintenance of weight loss when combined with a reduced-calorie diet.

Sibutramine belongs to a class of centrally acting medicines that were developed for weight-management treatment. Because medicines used for obesity can have important effects on the cardiovascular and nervous systems, treatment should be undertaken only under appropriate medical supervision.

The supplied information describes sibutramine hydrochloride monohydrate as a white to cream crystalline powder. Its reported solubility is 2.9 mg/mL in water at pH 5.2, with an octanol-to-water partition coefficient of 30.9 at pH 5.0.

Product Characteristics

Sibu-Med contains 20 mg of sibutramine hydrochloride per tablet. The oral tablet format provides a convenient pharmaceutical dosage form, while the pack contains 60 tablets.

The product information specifically states that sibutramine should be used as part of a broader weight-management approach involving a reduced-calorie diet. It should not be regarded as a substitute for dietary management or professional medical supervision.

Indication

The supplied information identifies Sibu-Med as being indicated for the management of obesity, including weight loss and maintenance of weight loss, in conjunction with a reduced-calorie diet.

Whether sibutramine is appropriate for an individual patient depends on their medical history, current medicines and overall health status. Treatment decisions should therefore be made by a qualified healthcare professional.

Side Effects

The supplied product information identifies several commonly reported adverse effects associated with sibutramine. These include:

• Dry mouth
• Reduced appetite (anorexia)
• Insomnia
• Constipation
• Headache

Patients should discuss persistent or concerning adverse effects with their healthcare professional.

Because sibutramine can affect appetite and central nervous system activity, professional monitoring is important during treatment.

Dosage and Administration

The supplied information states that dosage should be administered and supervised by a physician or doctor.

No individual dosing schedule should be inferred beyond the supplied information. Patients should follow the prescription and instructions provided by their healthcare professional and should not independently increase, reduce or extend treatment.

Storage

Store Sibu-Med in a cool, dry place and protect it from light.

Keep the product out of the reach of children.

Important Information

Sibu-Med is presented in the supplied information as a prescription medicine for obesity management. The information provided here is general product information and is not a substitute for individual medical advice.

Patients should consult a qualified healthcare professional before using sibutramine, particularly because medicines used for obesity management may not be suitable for everyone. Do not use or change the treatment regimen without appropriate medical supervision.

---

Product Specifications